These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 23116067)
1. Tranexamic acid solution soaking is an excellent approach for rosacea patients: a preliminary observation in six patients. Kim MS; Chang SE; Haw S; Bak H; Kim YJ; Lee MW J Dermatol; 2013 Jan; 40(1):70-1. PubMed ID: 23116067 [No Abstract] [Full Text] [Related]
2. The new therapeutic choice of tranexamic acid solution in treatment of erythematotelangiectatic rosacea. Bageorgou F; Vasalou V; Tzanetakou V; Kontochristopoulos G J Cosmet Dermatol; 2019 Apr; 18(2):563-567. PubMed ID: 30099833 [TBL] [Abstract][Full Text] [Related]
4. Intradermal tranexamic acid microinjections: a novel treatment option for erythematotelangiectatic rosacea. Daadaa N; Litaiem N; Karray M; Bacha T; Jones M; Belajouza Noueiri C; Goucha S; Zeglaoui F J Cosmet Dermatol; 2021 Oct; 20(10):3324-3329. PubMed ID: 33973361 [TBL] [Abstract][Full Text] [Related]
5. Combination treatment of propranolol, minocycline, and tranexamic acid for effective control of rosacea. Kwon HJ; Suh JH; Ko EJ; Kim BJ Dermatol Ther; 2017 May; 30(3):. PubMed ID: 27891741 [No Abstract] [Full Text] [Related]
6. Antifibrinolytic Use in the Perioperative Setting: Aminocaproic Acid and Tranexamic Acid. Golembiewski J J Perianesth Nurs; 2015 Dec; 30(6):560-563. PubMed ID: 26596393 [No Abstract] [Full Text] [Related]
7. Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma. Malik F; Hanif MM; Mustafa G J Coll Physicians Surg Pak; 2019 Jun; 29(6):502-504. PubMed ID: 31133144 [TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid--a recipe for saving lives in traumatic bleeding. Roberts I J Prim Health Care; 2011 Dec; 3(4):331. PubMed ID: 22132392 [No Abstract] [Full Text] [Related]
9. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia. Klepfish A; Berrebi A; Schattner A Arch Intern Med; 2001 Mar; 161(5):767. PubMed ID: 11231712 [No Abstract] [Full Text] [Related]
14. Use of a mucosal atomization device for local application of tranexamic acid in epistaxis. Heymer J; Schilling T; Räpple D Am J Emerg Med; 2018 Dec; 36(12):2327. PubMed ID: 29685357 [No Abstract] [Full Text] [Related]
15. Tranexamic acid and trauma. Jarman J; Brier A Med J Aust; 2014 Mar; 200(5):254. PubMed ID: 24641136 [No Abstract] [Full Text] [Related]
16. Tranexamic acid and trauma. Roberts I Med J Aust; 2014 Mar; 200(5):254-5. PubMed ID: 24641137 [No Abstract] [Full Text] [Related]
17. Tranexamic acid and trauma. Gruen RL; Jacobs IG; Reade MC Med J Aust; 2014 Mar; 200(5):255. PubMed ID: 24641138 [No Abstract] [Full Text] [Related]
18. Tranexamic acid and trauma coagulopathy: where are we now? Hanley C; Callum J; Jerath A Br J Anaesth; 2021 Jan; 126(1):12-17. PubMed ID: 33069339 [No Abstract] [Full Text] [Related]
19. Topical tranexamic acid (TXA) for the management of a bleeding arteriovenous fistula. Eberle ML; Schechter-Perkins EM; Altawil Z Am J Emerg Med; 2020 Feb; 38(2):407.e5-407.e6. PubMed ID: 31685307 [TBL] [Abstract][Full Text] [Related]
20. Does tranexamic acid reduce blood loss and blood transfusion requirement in knee arthroplasty? Atik OS Eklem Hastalik Cerrahisi; 2012; 23(3):166-7. PubMed ID: 23145761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]